Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azfar Zaman

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Lancet (London, England)|March 5, 2019
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trialAzfar Zaman, Robbert J de Winter, Norihiro Kogame, et al.
International Journal of Cardiology|November 14, 2021
A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCIDavid Adlam, Maciej Zarebinski, Neal G Uren, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 27, 2021
Survival relative to pacemaker status after transcatheter aortic valve implantationAung Myat, Florence Mouy, Luke Buckner, et al.
Nature Medicine|September 25, 2025
Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trialMichelle L O'Donoghue, David A Morrow, Andrea L Vavere, et al.
European Heart Journal|October 7, 2021
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II studyAdrian P Banning, Patrick Serruys, Giovanni Luigi De Maria, et al.
JACC. Cardiovascular Interventions|June 9, 2022
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONEStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
The New England Journal of Medicine|February 13, 2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding RiskStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
European Heart Journal|October 12, 2017
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II studyJavier Escaned, Carlos Collet, Nicola Ryan, et al.
Lancet (London, England)|November 7, 2016
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trialTimo Mäkikallio, Niels R Holm, Mitchell Lindsay, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Lancet (London, England)|March 5, 2019
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trialAzfar Zaman, Robbert J de Winter, Norihiro Kogame, et al.
International Journal of Cardiology|November 14, 2021
A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCIDavid Adlam, Maciej Zarebinski, Neal G Uren, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 27, 2021
Survival relative to pacemaker status after transcatheter aortic valve implantationAung Myat, Florence Mouy, Luke Buckner, et al.
Nature Medicine|September 25, 2025
Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trialMichelle L O'Donoghue, David A Morrow, Andrea L Vavere, et al.
European Heart Journal|October 7, 2021
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II studyAdrian P Banning, Patrick Serruys, Giovanni Luigi De Maria, et al.
JACC. Cardiovascular Interventions|June 9, 2022
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONEStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
The New England Journal of Medicine|February 13, 2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding RiskStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
European Heart Journal|October 12, 2017
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II studyJavier Escaned, Carlos Collet, Nicola Ryan, et al.
Lancet (London, England)|November 7, 2016
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trialTimo Mäkikallio, Niels R Holm, Mitchell Lindsay, et al.
Pageof 15